Medifast Inc (NYSE:MED) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.05-$2.15 for the period, compared to the Thomson Reuters consensus estimate of $2.02. The company issued revenue guidance of $290-$300 million, compared to the consensus revenue estimate of $288.65 million.Medifast also updated its Q3 guidance to $0.48-$0.51 EPS.
Several analysts have weighed in on MED shares. Sidoti cut shares of Medifast from a buy rating to a neutral rating in a research note on Tuesday, May 2nd. BidaskClub upgraded shares of Medifast from a strong sell rating to a sell rating in a research report on Friday, August 11th. Finally, DA Davidson began coverage on shares of Medifast in a research report on Wednesday. They set a buy rating for the company.
Medifast Inc (MED) traded up 0.07% during midday trading on Friday, hitting $55.82. 205,766 shares of the stock were exchanged. Medifast Inc has a one year low of $35.38 and a one year high of $56.41. The firm has a 50-day moving average price of $44.13 and a 200-day moving average price of $43.73. The stock has a market cap of $665.93 million, a P/E ratio of 28.05 and a beta of 0.48.
Medifast (NYSE:MED) last issued its earnings results on Tuesday, August 8th. The specialty retailer reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.10. Medifast had a return on equity of 24.25% and a net margin of 8.62%. The company had revenue of $75.70 million for the quarter, compared to analyst estimates of $71.96 million. During the same period in the prior year, the firm posted $0.63 EPS. The business’s revenue was up 6.5% compared to the same quarter last year. On average, equities research analysts anticipate that Medifast Inc will post $2.12 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 9th. Stockholders of record on Friday, June 23rd were issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date of this dividend was Wednesday, June 21st. Medifast’s dividend payout ratio is 64.32%.
COPYRIGHT VIOLATION WARNING: This news story was originally published by BBNS and is owned by of BBNS. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://baseballnewssource.com/markets/medifast-inc-med-updates-fy17-earnings-guidance-updated/1409448.html.
Medifast Company Profile
Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.
Receive News & Ratings for Medifast Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast Inc and related companies with our FREE daily email newsletter.